🔎 Trials Near Me

Home › Acute Myeloid Leukemia › Hawaii

Acute Myeloid Leukemia clinical trials in Hawaii

6 studies for Acute Myeloid Leukemia are looking for participants at sites in Hawaii.

Cities in Hawaii

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Straub Clinic and Hospital, Honolulu
  • Kaiser Permanente Moanalua Medical Center, Honolulu
  • and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Straub Clinic and Hospital, Honolulu
  • Kapiolani Medical Center for Women and Children, Honolulu
  • and 2 more
RecruitingPhase 2
Ages 18 to 59 · All sexes · Updated Nov 9, 2026 · NCT05554406

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Straub Clinic and Hospital, Honolulu
  • Kaiser Permanente Moanalua Medical Center, Honolulu
  • and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05564390

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • Kapiolani Medical Center for Women and Children, Honolulu
RecruitingPhase 3
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Kapiolani Medical Center for Women and Children, Honolulu
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.